JP2025517672A5 - - Google Patents
Info
- Publication number
- JP2025517672A5 JP2025517672A5 JP2024566410A JP2024566410A JP2025517672A5 JP 2025517672 A5 JP2025517672 A5 JP 2025517672A5 JP 2024566410 A JP2024566410 A JP 2024566410A JP 2024566410 A JP2024566410 A JP 2024566410A JP 2025517672 A5 JP2025517672 A5 JP 2025517672A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- chemical formula
- group
- formula
- glp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22172545.0 | 2022-05-10 | ||
| EP22172545 | 2022-05-10 | ||
| PCT/EP2023/062208 WO2023217744A1 (en) | 2022-05-10 | 2023-05-09 | Prodrugs of glp-1 polypeptide and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025517672A JP2025517672A (ja) | 2025-06-10 |
| JP2025517672A5 true JP2025517672A5 (cg-RX-API-DMAC7.html) | 2026-05-01 |
Family
ID=81940650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024566410A Pending JP2025517672A (ja) | 2022-05-10 | 2023-05-09 | プロドラッグおよびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250304645A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4522220A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025517672A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119173275A (cg-RX-API-DMAC7.html) |
| AR (1) | AR129270A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202346324A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023217744A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025092778A1 (zh) * | 2023-10-31 | 2025-05-08 | 深圳信立泰药业股份有限公司 | Glp-1化合物及其制备方法与应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7238671B2 (en) * | 2001-10-18 | 2007-07-03 | Bristol-Myers Squibb Company | Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| TWI362392B (en) | 2005-03-18 | 2012-04-21 | Novo Nordisk As | Acylated glp-1 compounds |
| PE20120332A1 (es) | 2008-12-19 | 2012-04-14 | Univ Indiana Res & Tech Corp | Profarmacos de peptido de la superfamilia de glucagon basado en amida |
| WO2010080605A1 (en) | 2008-12-19 | 2010-07-15 | Indiana University Research And Technology Corporation | Dipeptide linked medicinal agents |
| ES2401965T3 (es) | 2009-02-19 | 2013-04-25 | Novo Nordisk A/S | Modificación de Factor VIII |
| JP6006118B2 (ja) | 2009-12-16 | 2016-10-12 | ノヴォ ノルディスク アー／エス | Ｇｌｐ−１アナログ及び誘導体 |
| US9062094B2 (en) | 2010-01-22 | 2015-06-23 | Ascendis Pharma As | Dipeptide-based prodrug linkers for aliphatic amine-containing drugs |
| EP2588126A4 (en) | 2010-06-24 | 2015-07-08 | Univ Indiana Res & Tech Corp | AMID-BASED GLUCAGON SUPERFAMILY PEPTIDE PRODRUGS |
| JP6039569B2 (ja) | 2010-11-09 | 2016-12-07 | ノヴォ ノルディスク アー／エス | 二重アシル化されたｇｌｐ−１誘導体 |
| US9452225B2 (en) | 2012-03-01 | 2016-09-27 | Novo Nordisk A/S | GLP-1 prodrugs |
| JP2016521253A (ja) | 2013-03-15 | 2016-07-21 | インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション | 持続性作用を有するプロドラッグ |
| JP6701208B2 (ja) | 2014-09-24 | 2020-05-27 | インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション | 脂質化アミド系インスリンプロドラッグ |
| JP6898518B2 (ja) | 2018-02-02 | 2021-07-07 | ノヴォ ノルディスク アー／エス | Ｇｌｐ−１アゴニスト、ｎ−（８−（２−ヒドロキシベンゾイル）アミノ）カプリル酸の塩及び滑沢剤を含む固形組成物 |
| TWI829687B (zh) | 2018-05-07 | 2024-01-21 | 丹麥商諾佛 儂迪克股份有限公司 | 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物 |
-
2023
- 2023-05-09 AR ARP230101137A patent/AR129270A1/es unknown
- 2023-05-09 US US18/864,190 patent/US20250304645A1/en active Pending
- 2023-05-09 JP JP2024566410A patent/JP2025517672A/ja active Pending
- 2023-05-09 CN CN202380039160.4A patent/CN119173275A/zh active Pending
- 2023-05-09 TW TW112117140A patent/TW202346324A/zh unknown
- 2023-05-09 EP EP23726891.7A patent/EP4522220A1/en active Pending
- 2023-05-09 WO PCT/EP2023/062208 patent/WO2023217744A1/en not_active Ceased